Barry Snow described the results of the study as a "Rubiks Cube" where understanding how the results came about is a puzzle. That is what they are trying to do now, looking at all the characteristics of the individual patients and seeing if it has any relationship to the responses at a given dose. The longer the study time, the more data points they have, the better the chances they have of getting some insight.
Personally I don't believe they will pursue the PD use of NTcell if they cannot find some reasonable good scioentific evidence of efficacy in the data from the trial over 18-24 months. They would need to see a consistent trend which leads to statistical significance to seek and allocate more funds.
- Forums
- ASX - By Stock
- AGM
Barry Snow described the results of the study as a "Rubiks Cube"...
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $13.49M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $34 | 4.285K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 8215316 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1837858 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 8215316 | 0.007 |
11 | 5066749 | 0.006 |
8 | 6510009 | 0.005 |
4 | 4065000 | 0.004 |
2 | 4590000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1837858 | 8 |
0.009 | 1206691 | 9 |
0.010 | 2493145 | 4 |
0.011 | 1490400 | 3 |
0.012 | 363666 | 3 |
Last trade - 10.00am 04/09/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |